NEW YORK (GenomeWeb News) – Stephen Lombardi has left his job as president of Helicos BioSciences, and current CEO Ronald Lowy will take over the position, the company said in a recent filing with the US Securities and Exchange Commission. Lombardi, who also has resigned from the firm's board of directors, will receive the amount of his gross annual salary of $375,000 in severance, plus stock options. Lowy has been CEO since late 2007, and before that he was CEO and president of Fisher Biosciences, part of Thermo Fisher Scientific.
National Institutes of Health Deputy Director Raynard Kington will leave his position in July of this year to assume the role of president of Grinnell College in Iowa, NIH Director Francis Collins said in a statement this week.
Kington joined NIH in 2000 as director of the Office of Behavioral and Social Sciences Research, and since has served as acting director of the National Institute on Alcohol Abuse and Alcoholism, as principal deputy director of NIH, and as acting NIH director from November 2008 until August 2009.
"As Acting NIH Director, Raynard took on multiple challenges, including leading the effort to allocate $10.4 billion of Recovery Act money quickly and wisely, and implementing President Obama's executive order on human embryonic stem cell research," Collins said.
Scripps Research Institute at La Jolla, Calif., has appointed former US Congressman Dick Gephardt, former Ambassador Steven Green, and former Congresswoman Lynn Schenk to its Board of Trustees.
Gephardt served in the House of Representatives for 28 years as a representative from Missouri, and he was House Democratic Leader, Majority Leader, and Minority leader.
In Congress, Schenk represented the San Diego area, and served on the House Energy and Commerce Committee. She also was chief of staff for former California Governor Gray Davis between 1999 and 2003. She was reappointed to the board of trustees after having served on the board for several years already.
Green was ambassador to the Republic of Singapore from 1997 to 2001, a role in which he was able to work in the economic development, intellectual property, immigration, and national security areas.
The Human Genome Organization (HUGO) has re-elected Professor Edison Liu to continue serving as president of the organization. Liu is executive director of the Genome Institute of Singapore and he has been HUGO's president since 2007. Since assuming the presidency, Liu has overseen the initiation of the HUGO Journal, the restructuring of the organization's membership rules, and the establishment of web and social networking.
Caliper Life Sciences this week named its scientific advisory board for next-generation sequencing applications, which includes Michael Quail of the Wellcome Trust Sanger Institute; Vincent Magrini of the Washington University Genome Sequencing Center; Patrick Cahill of the Broad Institute of MIT and Harvard; Christopher Detter and Jan Fang Cheng of the US Department of Energy's Joint Genome Institute; and John Gill and Karen Beeson of the J. Craig Venter Institute. The company said that the board will be charged with guiding its efforts in automated sample preparation for next-generation and third-generation sequencing platforms.
Among the victims of a shooting rampage at the University of Alabama-Huntsville last week were genomics and genetics researchers Gopi Podila and Maria Ragland Davis. The alleged killer was a colleague of Podila and Davis in the biology department.
Podila was chair of the Department of Biological Sciences, and he specialized in functional genomics of plant-microbe interactions, and gene expression in plant molecular biology and biotechnology. Ragland Davis, an associate professor at UAH, specialized in plant genetics and molecular biology.
James Atwood has joined Australian bioseparations firm NuSep as vice president of sales, the company said this week. In addition, Brent Weatherly has been appointed NuSep's chief technology officer. Atwood was the CEO of proteomics software firm BioInquire, which Weatherly co-founded. NuSep this week announced it had signed a binding agreement to acquire BioInquire for up to $3 million.
Martin Schneider is now chair of the advisory board of imaGenes, the company said this week. Schneider replaces Klaus Schmidt-Menschner, who left to pursue other interests. Schneider is head of global therapeutic research at Bayer Schering Pharma. He was previously head of global target discovery and biomarkers at Bayer. Before that, he was head of enabling technologies at Schering. Based in Berlin, imaGenes provides genomics and proteomics services.
Vermillion this week announced Peter Roddy has joined its board, where he will chair the company' audit committee. Roddy is currently vice president and chief financial officer of Pain Therapeutics. Previously, he was senior vice president of finance and CFO of COR Therapeutics. He also has held finance positions at MCM Laboratories, Hewlett-Packard, and Price Waterhouse & Co., now called PricewaterhouseCoopers.
Linguamatics has appointed David Keilman as its director of channels and alliances, with responsibility for strategic partner relationships. He formerly held senior roles at 170 Systems, Sophos, and Genuity.
Millipore disclosed in a filing with the US Securities and Exchange Commission this week its 2009 Incentive Payments for its top executives, as well as their 2009 salaries.
Chairman, President, and CEO Martin Madaus received a 2009 incentive payment of $1.3 million and a base salary of $950,000 for 2009; CFO Charles Wagner received an incentive payment of $616,971 and a 2010 salary of $436,951; and VP of Global Operations Peter Kershaw received an incentive payment of $350,868 and a 2010 salary of $346, 490.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.